Published in Clin Pharmacol Ther on December 01, 1996
Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products. Clin Cancer Res (2010) 1.77
Strategic approaches to optimizing peptide ADME properties. AAPS J (2014) 1.14
Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100. Br J Cancer (2008) 0.85
The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. Br J Clin Pharmacol (2003) 0.85
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery. Invest New Drugs (2000) 0.83
The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy. J Pers Med (2012) 0.83
Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data. AAPS J (2009) 0.81
The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data. Pharm Res (2013) 0.79
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models. Clin Pharmacokinet (2016) 0.79
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination. AAPS J (2016) 0.78
Metabolism of BYZX in human liver microsomes and cytosol: identification of the metabolites and metabolic pathways of BYZX. PLoS One (2013) 0.75
Pimasertib, a selective oral MEK1/2 inhibitor: absolute bioavailability, mass balance, elimination route, and metabolite profile in cancer patients. Br J Clin Pharmacol (2016) 0.75
A comparative evaluation of models to predict human intestinal metabolism from nonclinical data. Biopharm Drug Dispos (2017) 0.75
Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA (1997) 10.23
A randomized, controlled trial of a home environmental intervention: effect on efficacy and upset in caregivers and on daily function of persons with dementia. Gerontologist (2001) 2.24
The economic burden of Alzheimer's disease care. Health Aff (Millwood) (1993) 2.22
Inbreeding effects on fertility in humans: evidence for reproductive compensation. Am J Hum Genet (1999) 2.17
Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet (1979) 2.08
The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Am J Epidemiol (1989) 2.04
Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. J Gen Intern Med (1995) 1.98
Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology (1994) 1.88
Evaluation of an HIV risk reduction intervention among African-American homosexual and bisexual men. AIDS (1996) 1.85
Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA (2001) 1.81
Lidocaine plasma protein binding. Clin Pharmacol Ther (1980) 1.74
Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care (2000) 1.70
Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology (1994) 1.68
The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS (1998) 1.64
The transitivity of bioequivalence testing: potential for drift. Int J Clin Pharmacol Ther (1996) 1.61
Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.55
Decreased fecundability in Hutterite couples sharing HLA-DR. Am J Hum Genet (1992) 1.52
Doctors who perform operations. A study on in-hospital surgery in four diverse geographic areas (first of two parts). N Engl J Med (1976) 1.48
Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst (1998) 1.48
Shared HLA antigens and reproductive performance among Hutterites. Am J Hum Genet (1983) 1.47
The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am J Med (2000) 1.45
Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat (1990) 1.45
Doctors who perform operations. A study on in-hospital surgery in four diverse geographic areas (second of two parts). N Engl J Med (1976) 1.44
A comment on the CDC study of nonsexual household transmission of AIDS and on Cameron's correction to that study. Psychol Rep (1989) 1.39
Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum Reprod (1998) 1.38
A proposal for interpreting and reporting negative studies. Stat Med (1986) 1.34
Smokeless tobacco use and health effects among baseball players. JAMA (1990) 1.33
Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol (2000) 1.31
Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol (1988) 1.30
Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (1997) 1.28
Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit (1983) 1.24
Vitamin K1 disposition and therapy of warfarin overdose. Lancet (1978) 1.20
Proportional hazards (Cox) regression. J Gen Intern Med (1993) 1.14
High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin. J Pharm Sci (1977) 1.14
Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension (1995) 1.12
Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (1999) 1.10
Improving family functioning after cardiac surgery: a randomized trial. Heart Lung (1990) 1.09
Are bisexually identified men in San Francisco a common vector for spreading HIV infection to women? Am J Public Health (1994) 1.09
Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health (1992) 1.08
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res (1986) 1.08
Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum (1996) 1.05
Prenatal zidovudine use and congenital anomalies in a medicaid population. J Acquir Immune Defic Syndr (2000) 1.05
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther (1995) 1.05
Adverse effects of human leukocyte antigen-DR sharing on fertility: a cohort study in a human isolate. Fertil Steril (1985) 1.04
Intersubject variability in the anticoagulant response to heparin in vitro. Eur J Clin Pharmacol (1982) 1.02
Methods for vascular access and collection of body fluids from the laboratory rat. J Pharm Sci (1983) 1.02
Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med (2001) 1.02
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology (Berl) (1985) 1.01
Multiple sexual partners and their psychosocial correlates: the population-based AIDS in multiethnic neighborhoods (AMEN) study. Health Psychol (1995) 1.00
Consideration of individual bioequivalence. J Pharmacokinet Biopharm (1990) 1.00
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res (1999) 0.99
Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther (1990) 0.99
A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. J Pharmacokinet Biopharm (1984) 0.99
Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. Cancer (2000) 0.98
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (1999) 0.97
Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases. J Clin Oncol (1997) 0.96
Recovery of upper-extremity strength in complete and incomplete tetraplegia: a multicenter study. Arch Phys Med Rehabil (2000) 0.96
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest (1985) 0.95
Measuring complete diagnostic evaluation in colorectal cancer screening. Cancer Detect Prev (2001) 0.95
Nomogram for estimating creatinine clearance. Clin Pharmacokinet (1983) 0.95
Determinants of the anticoagulant effect of heparin in vitro. Ann N Y Acad Sci (1981) 0.94
Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1. J Pharmacol Exp Ther (1979) 0.94
Diazepam and N-desmethyldiazepam redistribution after heparin. Clin Pharmacol Ther (1980) 0.94
HLA sharing and fertility in Hutterite couples: evidence for prenatal selection against compatible fetuses. Am J Reprod Immunol Microbiol (1988) 0.94
Surgeons in the United States. Activities, output and income. JAMA (1976) 0.94
Effects of a community intervention to change smoking behavior among Hispanics. Am J Prev Med (1995) 0.93
Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity. Biochem J (1989) 0.93
Pharmacometrics and the transition to model-based development. Clin Pharmacol Ther (2007) 0.92
Estimation of kinetic parameters from a two-point determination of the drug cumulation factor. Clin Pharmacol Ther (1979) 0.92
Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization. J Clin Immunol (2006) 0.90
Prenatal care and birth outcomes of a cohort of HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.89
The artifactual nature of heparin-induced drug protein-binding alterations. Clin Pharmacol Ther (1981) 0.89
Improved birth outcomes among HIV-infected women with enhanced Medicaid prenatal care. Am J Public Health (2000) 0.88
Heparin kinetics determined by three assay methods. Clin Pharmacol Ther (1982) 0.88
An annotated bibliography of methods for analysing correlated categorical data. Stat Med (1992) 0.88
Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Acta Neuropathol (1998) 0.88
Dipyridamol kinetics. Clin Pharmacol Ther (1982) 0.87
Design and organization of the herpetic eye disease study (HEDS). Curr Eye Res (1991) 0.87
Quantitating error in blood flow measurements with radioactive microspheres. Am J Physiol (1989) 0.87
Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations. Br J Clin Pharmacol (1989) 0.87
Models of care in New York State Medicaid substance abuse clinics. Range of services and linkages to medical care. J Subst Abuse (2000) 0.86
Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen. J Acquir Immune Defic Syndr (2001) 0.86
Improved birth outcomes associated with enhanced Medicaid prenatal care in drug-using women infected with the human immunodeficiency virus. Obstet Gynecol (1998) 0.86
Kinetics and metabolism of sulfinpyrazone. Clin Pharmacol Ther (1983) 0.85
Heparin administration increases plasma warfarin binding in man. Br J Clin Pharmacol (1979) 0.85
The large-sample relative efficiency of the Mantel-Haenszel estimator in the fixed-strata case. Biometrics (1986) 0.85
Jackknife bias reduction for polychotomous logistic regression. Stat Med (1997) 0.85
Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Circulation (1991) 0.85
Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid. J Vasc Surg (1988) 0.85
Oral dipyridamole increases plasma adenosine levels in human beings. Clin Pharmacol Ther (1989) 0.84
Wheat gluten challenge in schizophrenic patients. Am J Psychiatry (1981) 0.83
Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women. Ann Intern Med (1999) 0.83
A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer. J Clin Oncol (1984) 0.83
Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol (1993) 0.83
A randomized clinical trial of nursing care for recovery from cardiac surgery. Heart Lung (1993) 0.83
Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer. Tech Urol (2000) 0.83
Bioequivalence: performance of several measures of extent of absorption. Pharm Res (1994) 0.82
Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction. J Pharmacol Exp Ther (1979) 0.82
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension (1993) 0.82
Pharmacokinetics of streptokinase in patients based on amidolytic activator complex activity. Clin Pharmacol Ther (1987) 0.82